Mortality Risk Over Time in Patients with Carbapenem-Resistant Gram-Negative Bloodstream Infections: Implications for Recruitment and Timing of Primary Endpoints in Clinical Trials.

Abi Manesh, Nagaraj Veerasamy, Pooja Shah, Prasannakumar Palanikumar, Sakshi Parasrampuria, Balaji Veeraraghavan, George M Varghese, David L Paterson, A Sarah Walker

DOI: 10.1016/j.ijantimicag.2026.108061

На странице источника доступны аннотация, полный текст или сведения о том, где его прочитать.